Skip to main content
Benjamin Purow, MD, Neurology, Charlottesville, VA

Benjamin Warren Purow MD

Neurooncology


Associate Professor, Neurology, University of Virginia School of Medicine

Join to View Full Profile
  • 1240 Lee StCharlottesville, VA 22908

  • Phone+1 434-924-9333

  • Fax+1 434-244-7526

Dr. Purow is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1999 - 2002
  • Children's National Hospital
    Children's National HospitalResidency, Pediatrics, 1996 - 1999
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1996

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2006 - 2026
  • MD State Medical License
    MD State Medical License 1999 - 2015
  • DC State Medical License
    DC State Medical License 1997 - 2000
  • Pediatrics
    American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Combined c-met/Trk Inhibition Overcomes Resistance to CDK4/6 Inhibitors in Glioblastoma  
    Ichiro Nakano, Benjamin Purow, Clinical Cancer Research

Press Mentions

  • Ribociclib Shown to Penetrate the Blood-Brain Barrier in Glioblastoma
    Ribociclib Shown to Penetrate the Blood-Brain Barrier in GlioblastomaSeptember 13th, 2019

Grant Support

  • Novel immunotherapeutic potential of DGKalpha inhibition for glioblastomaUNIVERSITY OF VIRGINIA2022–2027
  • Vulnerabilities of MMR-deficient glioblastomaUNIVERSITY OF VIRGINIA2022–2027
  • Investigation Of Notch-Inhibiting Micrornas In GliomaNational Cancer Institute2009–2012
  • Investigating Alpha-Secretase Inhibitors As Notch Inhibitors &Anti-Glioma AgentsNational Cancer Institute2008–2011

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: